Natural killer (NK) cells are a specialized type of white blood cell that belongs to the innate immune system, the body’s first line of defense. They are identified in the lab by the absence of a protein called CD3 and the presence of proteins called CD16 and CD56. These markers are essentially “tags” on the cell surface that tell scientists and doctors what kind of immune cell they are looking at.
NK cells play two broad roles. The first is direct attack: they can recognize and kill virus-infected or cancerous cells without needing prior “training” from the immune system. They do this by releasing toxic proteins such as granzyme B that trigger the abnormal cell to self-destruct. The second role is regulation: NK cells release signaling proteins, or cytokines, that guide other immune cells to respond appropriately, sometimes amplifying and sometimes calming the response.
NK Cell Subsets
- CD56dim CD16+ NK cells are the majority in the bloodstream. They are highly cytotoxic, meaning they specialize in direct killing. They provide rapid defense against infections and malignant cells.
- CD56bright CD16– NK cells are less effective at killing but excel at producing cytokines. They help coordinate the immune response and are found more often in tissues than in blood. They may become more abundant after bone marrow transplantation or within tumor environments.
- CD56neg CD16+ NK cells are rare in healthy individuals but expand in chronic viral infections such as HIV-1. Their role is still being understood, but they appear to represent a unique stage of NK cell development or activation, with altered functionality compared to other subsets.
Clinical Significance
- In infections, such as HIV, the unusual CD56neg CD16+ subset often expands, reflecting changes in immune regulation.
- In cancer, NK cells influence outcomes both in blood and in tumor tissues. For instance, higher numbers of CD56bright NK cells within a tumor may be linked with better survival, while certain checkpoint-marker–positive NK cells can predict who will respond to modern immunotherapy drugs.
- In immune recovery, such as after bone marrow transplantation, NK cells are among the first lymphocytes to reappear. The order in which subsets re-emerge provides insight into how the immune system is rebuilding itself.
Measuring the absolute count of NK cells (CD3–CD16+CD56+) offers a window into how the immune system is functioning.
Instalab